更多...
收起
BRCA1基因(以及对应的蛋白质)的细胞分布位置:
BRCA1基因的本体(GO)信息:
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Hereditary Breast and Ovarian Cancer Syndrome | 0.419988654 | 221 | 113 | BeFree_CLINVAR_CTD_human_ORPHANET |
| Malignant neoplasm of breast | 0.36 | 2339 | 76 | BeFree_GAD_MGD_UNIPROT |
| BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 | 0.36 | 1 | 973 | CLINVAR_CTD_human_UNIPROT |
| Mammary Neoplasms | 0.32641656 | 391 | 0 | BeFree_CTD_human_GAD_LHGDN |
| ovarian neoplasm | 0.301443908 | 213 | 1 | BeFree_CTD_human_GAD_LHGDN |
| Malignant neoplasm of ovary | 0.28 | 1463 | 23 | BeFree_GAD_UNIPROT |
| Animal Mammary Neoplasms | 0.2 | 79 | 0 | CTD_human_GAD |
| Mammary Neoplasms, Experimental | 0.2 | 1 | 0 | CTD_human_RGD |
| Breast Cancer, Familial | 0.195656337 | 270 | 704 | BeFree_CLINVAR_GAD |
| Prostatic Neoplasms | 0.144989972 | 16 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Pancreatic Neoplasm | 0.142017924 | 10 | 0 | CTD_human_GAD_LHGDN |
| FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.12868614 | 32 | 2 | BeFree_CLINVAR |
| Neoplastic Syndromes, Hereditary | 0.126091273 | 7 | 286 | BeFree_CLINVAR_GAD |
| Chromosome Breakage | 0.124734064 | 2 | 0 | CTD_human_GAD |
| Neoplastic Cell Transformation | 0.122367032 | 2 | 0 | CTD_human_GAD |
| Prostate cancer, familial | 0.121357209 | 5 | 0 | BeFree_ORPHANET |
| Pancreatic carcinoma, familial | 0.120542884 | 2 | 0 | BeFree_ORPHANET |
| Adenoid Cystic Carcinoma | 0.12 | 1 | 0 | CTD_human |
| Mouth Diseases | 0.12 | 1 | 0 | CTD_human |
| Peripheral Neuropathy | 0.12 | 1 | 0 | CTD_human |
| PANCREATIC CANCER, SUSCEPTIBILITY TO, 4 | 0.12 | 0 | 1 | CLINVAR |
| Ovarian Carcinoma | 0.082367032 | 1483 | 23 | BeFree_GAD |
| Hypertensive disease | 0.08 | 1 | 0 | RGD |
| Breast Carcinoma | 0.08 | 2126 | 70 | BeFree |
| Malignant neoplasm of prostate | 0.048024143 | 82 | 0 | BeFree_GAD |
| Carcinogenesis | 0.045602235 | 168 | 3 | BeFree |
| Sporadic Breast Carcinoma | 0.038001862 | 140 | 1 | BeFree |
| Epithelial ovarian cancer | 0.031954196 | 110 | 4 | BeFree_GAD |
| Triple Negative Breast Neoplasms | 0.022258234 | 82 | 1 | BeFree |
| Fallopian Tube Neoplasms | 0.021660606 | 9 | 0 | GAD_LHGDN |
| Prostate carcinoma | 0.020086699 | 74 | 0 | BeFree |
| Breast Neoplasms, Male | 0.017912621 | 8 | 0 | BeFree_GAD_LHGDN |
| Noninfiltrating Intraductal Carcinoma | 0.016340051 | 25 | 0 | BeFree_GAD_LHGDN |
| Colorectal Cancer | 0.016254175 | 25 | 0 | BeFree_GAD |
| melanoma | 0.014906897 | 14 | 0 | BeFree_GAD_LHGDN |
| Adenocarcinoma | 0.013525943 | 13 | 0 | BeFree_GAD_LHGDN |
| Carcinoma of Male Breast | 0.011867498 | 35 | 0 | BeFree_GAD |
| Malignant neoplasm of male breast | 0.011400559 | 42 | 0 | BeFree |
| Contralateral breast cancer | 0.010857675 | 40 | 0 | BeFree |
| Colorectal Neoplasms | 0.010182764 | 4 | 0 | GAD_LHGDN |
| Fanconi Anemia | 0.010043349 | 37 | 0 | BeFree |
| Neoplasm Metastasis | 0.009771907 | 36 | 0 | BeFree |
| Peritoneal Neoplasms | 0.00973957 | 5 | 0 | BeFree_GAD |
| DNA Damage | 0.009468128 | 4 | 0 | GAD |
| Neoplasm Invasiveness | 0.009468128 | 4 | 0 | GAD |
| Malignant neoplasm of lung | 0.009001189 | 10 | 0 | BeFree_GAD |
| Non-Small Cell Lung Carcinoma | 0.008957582 | 33 | 1 | BeFree |
| Hereditary Nonpolyposis Colorectal Cancer | 0.008957582 | 33 | 0 | BeFree |
| Pancreatic carcinoma | 0.008143256 | 30 | 0 | BeFree |
| Malignant neoplasm of pancreas | 0.008143256 | 30 | 0 | BeFree |
| Invasive Ductal Breast Carcinoma | 0.007915422 | 6 | 0 | BeFree_GAD |
| Hereditary Malignant Neoplasm | 0.007057489 | 26 | 0 | BeFree |
| Colorectal Carcinoma | 0.006786047 | 25 | 0 | BeFree |
| Invasive breast carcinoma | 0.006786047 | 25 | 0 | BeFree |
| Tumor Progression | 0.006710102 | 16 | 0 | BeFree_GAD |
| Endometrial Carcinoma | 0.00643866 | 16 | 0 | BeFree_GAD |
| Fallopian Tube Carcinoma | 0.005971721 | 22 | 0 | BeFree |
| Leukemia, Myelocytic, Acute | 0.005905708 | 4 | 0 | BeFree_GAD_LHGDN |
| Cystadenocarcinoma, Serous | 0.005624334 | 13 | 0 | BeFree_GAD |
| Lymphoma | 0.00554839 | 4 | 0 | BeFree_GAD |
| Precancerous Conditions | 0.00554839 | 5 | 0 | BeFree_GAD |
| Spina Bifida | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
| Neoplasms, Second Primary | 0.005362824 | 2 | 0 | BeFree_GAD_LHGDN |
| Lymphoma, Non-Hodgkin | 0.005276948 | 3 | 4 | BeFree_GAD |
| bilateral breast cancer | 0.005157396 | 19 | 0 | BeFree |
| Endometrial Neoplasms | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Stomach Neoplasms | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Malignant neoplasm of urinary bladder | 0.005005506 | 3 | 0 | BeFree_GAD |
| Brain Neoplasms | 0.005005506 | 3 | 0 | BeFree_GAD |
| Colonic Neoplasms | 0.005005506 | 3 | 0 | BeFree_GAD |
| Neoplasm Recurrence, Local | 0.004734064 | 2 | 0 | GAD |
| Neoplasms, Multiple Primary | 0.004734064 | 2 | 0 | GAD |
| Skin Neoplasms | 0.004734064 | 2 | 0 | GAD |
| Unilateral Breast Carcinoma | 0.004614512 | 17 | 2 | BeFree |
| Female Breast Carcinoma | 0.00434307 | 16 | 0 | BeFree |
| Malignant tumor of peritoneum | 0.00434307 | 16 | 0 | BeFree |
| Squamous cell carcinoma | 0.00408156 | 5 | 0 | BeFree_LHGDN |
| Congenital chromosomal disease | 0.004071628 | 15 | 0 | BeFree |
| Malignant neoplasm of fallopian tube | 0.004071628 | 15 | 0 | BeFree |
| Malignant neoplasm of female breast | 0.003800186 | 14 | 0 | BeFree |
| Myeloid Leukemia, Chronic | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| Malignant neoplasm of stomach | 0.003528744 | 13 | 1 | BeFree |
| Stomach Carcinoma | 0.003528744 | 13 | 1 | BeFree |
| Glioblastoma | 0.003452799 | 5 | 0 | BeFree_GAD |
| Endometriosis | 0.003267234 | 3 | 0 | BeFree_LHGDN |
| psychological distress | 0.003257302 | 12 | 0 | BeFree |
| Cervix carcinoma | 0.003181358 | 3 | 1 | BeFree_GAD |
| Microcephaly | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Premature Menopause | 0.002909916 | 2 | 0 | BeFree_GAD |
| Diffuse Large B-Cell Lymphoma | 0.002909916 | 3 | 0 | BeFree_GAD |
| Alzheimer's Disease | 0.00272435 | 1 | 0 | LHGDN |
| Anoxia | 0.00272435 | 1 | 0 | LHGDN |
| Head and Neck Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Behavioral tic | 0.00272435 | 1 | 0 | LHGDN |
| Ataxia Telangiectasia | 0.002714419 | 10 | 0 | BeFree |
| Secondary malignant neoplasm of lymph node | 0.002714419 | 10 | 0 | BeFree |
| High grade serous carcinoma | 0.002714419 | 10 | 0 | BeFree |
| Glioma | 0.002638474 | 2 | 0 | BeFree_GAD |
| Lymphoma, Follicular | 0.002638474 | 2 | 0 | BeFree_GAD |
| Meningomyelocele | 0.002638474 | 1 | 0 | BeFree_GAD |
| Mixed Salivary Gland Tumor | 0.002638474 | 1 | 0 | BeFree_GAD |
| Multiple Sclerosis | 0.002638474 | 2 | 0 | BeFree_GAD |
| Carcinoma, Lobular | 0.002638474 | 2 | 0 | BeFree_GAD |
| Mammary Tumorigenesis | 0.002442977 | 9 | 0 | BeFree |
| BREAST CANCER 3 | 0.002442977 | 9 | 0 | BeFree |
| Basal cell carcinoma | 0.002367032 | 1 | 0 | GAD |
| Chromosome Aberrations | 0.002367032 | 1 | 0 | GAD |
| Hodgkin Disease | 0.002367032 | 1 | 0 | GAD |
| Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
| Lymphatic Metastasis | 0.002367032 | 1 | 0 | GAD |
| Narcolepsy | 0.002367032 | 1 | 0 | GAD |
| Ovarian Diseases | 0.002367032 | 1 | 0 | GAD |
| Salivary Gland Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Tobacco Use Disorder | 0.002367032 | 1 | 0 | GAD |
| Uveal Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Coronary spastic angina | 0.002367032 | 1 | 0 | GAD |
| Malignant tumor of colon | 0.002171535 | 8 | 0 | BeFree |
| Malignant neoplasm of endometrium | 0.002171535 | 8 | 0 | BeFree |
| Adenocarcinoma of pancreas | 0.002171535 | 8 | 0 | BeFree |
| Papillary serous cystadenocarcinoma | 0.002171535 | 8 | 0 | BeFree |
| Colon Carcinoma | 0.002171535 | 8 | 0 | BeFree |
| Uterine Corpus Cancer | 0.002171535 | 8 | 0 | BeFree |
| Trigeminal Neuralgia | 0.001900093 | 7 | 0 | BeFree |
| Li-Fraumeni Syndrome | 0.001900093 | 7 | 1 | BeFree |
| Carcinoma breast stage IV | 0.001900093 | 7 | 0 | BeFree |
| Anxiety Disorders | 0.001628651 | 6 | 0 | BeFree |
| Adenomatous Polyposis Coli | 0.001628651 | 6 | 0 | BeFree |
| Carcinoma of lung | 0.001628651 | 6 | 0 | BeFree |
| Carcinoma of peritoneum | 0.001628651 | 6 | 0 | BeFree |
| Sarcoma | 0.001628651 | 6 | 0 | BeFree |
| leukemia | 0.001357209 | 5 | 0 | BeFree |
| Nephroblastoma | 0.001357209 | 5 | 0 | BeFree |
| Malignant Female Reproductive System Neoplasm | 0.001357209 | 5 | 0 | BeFree |
| Ductal Carcinoma | 0.001357209 | 5 | 0 | BeFree |
| Atypical medullary carcinoma | 0.001357209 | 5 | 0 | BeFree |
| Hamartoma Syndrome, Multiple | 0.001085767 | 4 | 0 | BeFree |
| Stage 0 Breast Carcinoma | 0.001085767 | 4 | 0 | BeFree |
| invasive cancer | 0.001085767 | 4 | 0 | BeFree |
| Medullary carcinoma of breast | 0.001085767 | 4 | 0 | BeFree |
| Borderline ovarian tumour | 0.001085767 | 4 | 0 | BeFree |
| Pancreatic Ductal Adenocarcinoma | 0.001085767 | 4 | 0 | BeFree |
| Mammographic Density | 0.001085767 | 4 | 0 | BeFree |
| Li-Fraumeni-Like Syndrome | 0.001085767 | 4 | 0 | BeFree |
| Early-Stage Breast Carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Mental Depression | 0.000814326 | 3 | 0 | BeFree |
| Depressive disorder | 0.000814326 | 3 | 0 | BeFree |
| Breast Fibrocystic Disease | 0.000814326 | 3 | 0 | BeFree |
| HIV Infections | 0.000814326 | 3 | 0 | BeFree |
| Depressive Symptoms | 0.000814326 | 3 | 0 | BeFree |
| Medullary carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Ovarian epithelial cancer recurrent | 0.000814326 | 3 | 0 | BeFree |
| Squamous cell carcinoma of esophagus | 0.000814326 | 3 | 0 | BeFree |
| Carcinoma in situ of fallopian tube | 0.000814326 | 3 | 0 | BeFree |
| Nijmegen Breakage Syndrome | 0.000814326 | 3 | 0 | BeFree |
| Breast adenocarcinoma | 0.000814326 | 3 | 0 | BeFree |
| Intraepithelial Neoplasia | 0.000814326 | 3 | 0 | BeFree |
| precancerous lesions | 0.000814326 | 3 | 0 | BeFree |
| Squamous cell carcinoma of the head and neck | 0.000814326 | 3 | 0 | BeFree |
| Invasive Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Primary Peritoneal Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Adenoma | 0.000542884 | 2 | 0 | BeFree |
| Benign Ovarian Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Bloom Syndrome | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of larynx | 0.000542884 | 2 | 0 | BeFree |
| Carcinoma, Papillary | 0.000542884 | 2 | 0 | BeFree |
| Renal Cell Carcinoma | 0.000542884 | 2 | 1 | BeFree |
| Carcinoma, Transitional Cell | 0.000542884 | 2 | 0 | BeFree |
| Malignant tumor of cervix | 0.000542884 | 2 | 1 | BeFree |
| Cystadenoma | 0.000542884 | 2 | 0 | BeFree |
| Cystic Fibrosis | 0.000542884 | 2 | 0 | BeFree |
| Cyst | 0.000542884 | 2 | 0 | BeFree |
| Diabetes Mellitus | 0.000542884 | 2 | 0 | BeFree |
| Esophageal Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| leiomyosarcoma | 0.000542884 | 2 | 0 | BeFree |
| Chronic Lymphocytic Leukemia | 0.000542884 | 2 | 0 | BeFree |
| Neurofibromatosis 1 | 0.000542884 | 2 | 0 | BeFree |
| Retinoblastoma | 0.000542884 | 2 | 0 | BeFree |
| Turner Syndrome | 0.000542884 | 2 | 0 | BeFree |
| Vascular Diseases | 0.000542884 | 2 | 0 | BeFree |
| Ichthyosis, X-Linked | 0.000542884 | 2 | 0 | BeFree |
| Lymphoma, Large-Cell, Follicular | 0.000542884 | 2 | 4 | BeFree |
| Ovarian Failure, Premature | 0.000542884 | 2 | 0 | BeFree |
| Cutaneous Melanoma | 0.000542884 | 2 | 0 | BeFree |
| Esophageal carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Uterine Cancer | 0.000542884 | 2 | 0 | BeFree |
| Secondary malignant neoplasm of lung | 0.000542884 | 2 | 0 | BeFree |
| Agenesis of corpus callosum | 0.000542884 | 2 | 0 | BeFree |
| Familial Atypical Multiple Mole-Melanoma | 0.000542884 | 2 | 0 | BeFree |
| Uveal melanoma | 0.000542884 | 2 | 0 | BeFree |
| Spastic syndrome | 0.000542884 | 2 | 0 | BeFree |
| Malignant Childhood Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| stage, ovarian epithelial cancer | 0.000542884 | 2 | 0 | BeFree |
| Dysgerminoma of ovary | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of esophagus | 0.000542884 | 2 | 0 | BeFree |
| Premenopausal breast cancer | 0.000542884 | 2 | 0 | BeFree |
| Pelvic Cancer | 0.000542884 | 2 | 0 | BeFree |
| Lymphocytic infiltration | 0.000542884 | 2 | 0 | BeFree |
| Metaplastic carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Hereditary Ovarian Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Metaplastic breast carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Cancer Cell Growth | 0.000542884 | 2 | 0 | BeFree |
| Ductal Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Non-Neoplastic Disorder | 0.000542884 | 2 | 0 | BeFree |
| Contralateral Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Amenorrhea | 0.000271442 | 1 | 0 | BeFree |
| Anaplasia | 0.000271442 | 1 | 0 | BeFree |
| Anemia | 0.000271442 | 1 | 0 | BeFree |
| Arteriosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Atherosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Bladder Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Cardiomyopathy, Dilated | 0.000271442 | 1 | 0 | BeFree |
| Cardiovascular Diseases | 0.000271442 | 1 | 0 | BeFree |
| Primary biliary cirrhosis | 0.000271442 | 1 | 0 | BeFree |
| Colitis | 0.000271442 | 1 | 0 | BeFree |
| Diabetes | 0.000271442 | 1 | 0 | BeFree |
| Nonproliferative fibrocystic disease | 0.000271442 | 1 | 0 | BeFree |
| Folic Acid Deficiency | 0.000271442 | 1 | 0 | BeFree |
| Genital Neoplasms, Female | 0.000271442 | 1 | 0 | BeFree |
| granulosa cell tumor | 0.000271442 | 1 | 0 | BeFree |
| Gynecomastia | 0.000271442 | 1 | 0 | BeFree |
| Heart failure | 0.000271442 | 1 | 0 | BeFree |
| Congestive heart failure | 0.000271442 | 1 | 0 | BeFree |
| Hemangiosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Hemophilia A | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis A | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis B | 0.000271442 | 1 | 0 | BeFree |
| Hyperthyroidism | 0.000271442 | 1 | 0 | BeFree |
| Immunologic Deficiency Syndromes | 0.000271442 | 1 | 0 | BeFree |
| insulinoma | 0.000271442 | 1 | 0 | BeFree |
| Krukenberg Tumor | 0.000271442 | 1 | 0 | BeFree |
| Laryngeal neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, Myeloid, Chronic-Phase | 0.000271442 | 1 | 0 | BeFree |
| Leukopenia | 0.000271442 | 1 | 0 | BeFree |
| Leukoplakia | 0.000271442 | 1 | 0 | BeFree |
| Waldenstrom Macroglobulinemia | 0.000271442 | 1 | 0 | BeFree |
| Meningioma | 0.000271442 | 1 | 0 | BeFree |
| Mesothelioma | 0.000271442 | 1 | 0 | BeFree |
| Moyamoya Disease | 0.000271442 | 1 | 0 | BeFree |
| Multiple Myeloma | 0.000271442 | 1 | 0 | BeFree |
| Myocardial Infarction | 0.000271442 | 1 | 0 | BeFree |
| Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
| Neurofibromatosis 2 | 0.000271442 | 1 | 0 | BeFree |
| Neutropenia | 0.000271442 | 1 | 0 | BeFree |
| Obesity | 0.000271442 | 1 | 0 | BeFree |
| Osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Peritonitis | 0.000271442 | 1 | 0 | BeFree |
| Peutz-Jeghers Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Pneumonia | 0.000271442 | 1 | 0 | BeFree |
| Septicemia | 0.000271442 | 1 | 0 | BeFree |
| Sleep disturbances | 0.000271442 | 1 | 0 | BeFree |
| Post-Traumatic Stress Disorder | 0.000271442 | 1 | 0 | BeFree |
| Thrombasthenia | 0.000271442 | 1 | 0 | BeFree |
| Tongue Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Tuberculosis | 0.000271442 | 1 | 0 | BeFree |
| Tuberous Sclerosis | 0.000271442 | 1 | 0 | BeFree |
| Werner Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Severe Combined Immunodeficiency | 0.000271442 | 1 | 0 | BeFree |
| Adenosis of Breast | 0.000271442 | 1 | 0 | BeFree |
| Benign Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Rous Sarcoma | 0.000271442 | 1 | 0 | BeFree |
| Adnexal mass | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma of lung (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of tongue | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of abdomen | 0.000271442 | 1 | 0 | BeFree |
| Aortic Aneurysm, Thoracic | 0.000271442 | 1 | 0 | BeFree |
| Microinvasive tumor | 0.000271442 | 1 | 0 | BeFree |
| Undifferentiated carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Amyloid Neuropathies | 0.000271442 | 1 | 0 | BeFree |
| Mixed Tumor, Mullerian | 0.000271442 | 1 | 0 | BeFree |
| Sebaceous Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Acinar Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma, Large Cell | 0.000271442 | 1 | 0 | BeFree |
| Comedone | 0.000271442 | 1 | 0 | BeFree |
| Premature aging syndrome | 0.000271442 | 1 | 0 | BeFree |
| Difficulty sleeping | 0.000271442 | 1 | 0 | BeFree |
| Papillary thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Neoplasm, Residual | 0.000271442 | 1 | 0 | BeFree |
| Sepsis | 0.000271442 | 1 | 0 | BeFree |
| Multiple tumors | 0.000271442 | 1 | 0 | BeFree |
| Xeroderma pigmentosum, group G | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma breast stage I | 0.000271442 | 1 | 0 | BeFree |
| Breast cancer stage II | 0.000271442 | 1 | 0 | BeFree |
| Non-small cell lung cancer stage I | 0.000271442 | 1 | 0 | BeFree |
| Non-small cell lung cancer metastatic | 0.000271442 | 1 | 0 | BeFree |
| Lobular carcinoma in situ of breast | 0.000271442 | 1 | 0 | BeFree |
| Acinar cell carcinoma of pancreas | 0.000271442 | 1 | 0 | BeFree |
| Solid tumour | 0.000271442 | 1 | 0 | BeFree |
| Leiomyosarcoma of uterus | 0.000271442 | 1 | 0 | BeFree |
| Non-infiltrating lobular carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Malignant lymphoma - lymphoplasmacytic | 0.000271442 | 1 | 0 | BeFree |
| Mixed anxiety and depressive disorder | 0.000271442 | 1 | 0 | BeFree |
| Malignant mesothelioma | 0.000271442 | 1 | 0 | BeFree |
| Benign neoplasm of breast | 0.000271442 | 1 | 0 | BeFree |
| Secondary malignant neoplasm of pancreas | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of tongue | 0.000271442 | 1 | 0 | BeFree |
| Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | 0.000271442 | 1 | 0 | BeFree |
| Loss of interest | 0.000271442 | 1 | 0 | BeFree |
| Occult carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Sleep Apnea, Obstructive | 0.000271442 | 1 | 0 | BeFree |
| Recurrent tumor | 0.000271442 | 1 | 0 | BeFree |
| Metabolic Syndrome X | 0.000271442 | 1 | 0 | BeFree |
| Recurrent Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Tongue Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Lymphoid neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Tumor Initiation | 0.000271442 | 1 | 0 | BeFree |
| Progressive Neoplastic Disease | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma of bladder | 0.000271442 | 1 | 0 | BeFree |
| Central neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
| Anxiety state | 0.000271442 | 1 | 0 | BeFree |
| Postsurgical menopause | 0.000271442 | 1 | 0 | BeFree |
| Medullary Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Sleep Disorders | 0.000271442 | 1 | 0 | BeFree |
| Oestrogen deficiency | 0.000271442 | 1 | 0 | BeFree |
| Endothelial dysfunction | 0.000271442 | 1 | 0 | BeFree |
| Ovarian adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Colorectal cancer metastatic | 0.000271442 | 1 | 0 | BeFree |
| Salivary gland carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Small cell carcinoma of esophagus | 0.000271442 | 1 | 8 | BeFree |
| Stage IV Esophageal Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Mammary Carcinoma, Human | 0.000271442 | 1 | 0 | BeFree |
| Anxiety neurosis (finding) | 0.000271442 | 1 | 0 | BeFree |
| Precursor B-cell lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
| Congenital malformation syndrome | 0.000271442 | 1 | 0 | BeFree |
| Hereditary Non-Polyposis Colon Cancer Type 2 | 0.000271442 | 1 | 0 | BeFree |
| Locally Metastatic Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Breast Microglandular Adenosis | 0.000271442 | 1 | 0 | BeFree |
| Ovarian Serous Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Treatment related acute myeloid leukaemia | 0.000271442 | 1 | 0 | BeFree |
| Differentiated Thyroid Gland Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Metastatic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Cardiomyopathy, Familial Idiopathic | 0.000271442 | 1 | 0 | BeFree |
| Ovarian Clear Cell Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Tumor Immunity | 0.000271442 | 1 | 0 | BeFree |
| Xenograft Model | 0.000271442 | 1 | 0 | BeFree |
| Apocrine Gland Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| HYPERTRICHOSIS, CONGENITAL GENERALIZED | 0.000271442 | 1 | 0 | BeFree |
| Breast Cancer, Familial Male | 0.000271442 | 1 | 0 | BeFree |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| malignant neoplasm of breast stage I | 0.000271442 | 1 | 0 | BeFree |
| malignant neoplasm of breast staging | 0.000271442 | 1 | 0 | BeFree |
| Liver carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Riddle Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Promyelocytic leukemia | 0.000271442 | 1 | 0 | BeFree |
| Nasopharyngeal carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Limb ischemia | 0.000271442 | 1 | 0 | BeFree |
| aggressive cancer | 0.000271442 | 1 | 0 | BeFree |
| Multifocal Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Progressive cGVHD | 0.000271442 | 1 | 0 | BeFree |
| Breast cancer, lobular | 0.000271442 | 1 | 0 | BeFree |
| Basal-Like Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Secondary malignant neoplasm of ovary | 0.000271442 | 1 | 0 | BeFree |
| Diminished ovarian reserve | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。